SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Molyneux, P. D
Right arrow Articles by Miller, D. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molyneux, P. D
Right arrow Articles by Miller, D. H
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study

Paul D Molyneux

NMR Research Unit, Institute of Neurology, National Hospital, Queen Square, London, UK

Peter A Brex

NMR Research Unit, Institute of Neurology, National Hospital, Queen Square, London, UK

Caroline Fogg

NMR Research Unit, Institute of Neurology, National Hospital, Queen Square, London, UK

Sara Lewis

NMR Research Unit, Institute of Neurology, National Hospital, Queen Square, London, UK

Claire Middleditch

NMR Research Unit, Institute of Neurology, National Hospital, Queen Square, London, UK

Frederik Barkhof

MRI Centre for MS Research and Radiology, Academic Hospital of the Vrije Universiteit, Amsterdam, The Netherlands

Maria P Sormani

Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San Raffaele, University of Milan, Milan, Italy

Massimo Filippi

Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San Raffaele, University of Milan, Milan, Italy

David H Miller

NMR Research Unit, Institute of Neurology, National Hospital, Queen Square, London, UK

The volume of hypointense lesions on T1 weighted brain MRI represents an increasingly used MR endpoint in phase III MS treatment trials. In this study we evaluated the reproducibility of hypointense T1 lesion volume quantification in a cohort of Multiple Sclerosis (MS) patients. The gadolinium enhanced T1 weighted brain MR images of 33 MS patients from three European centers were used in this study. These images were acquired as part of a phase III trial of interferon beta-1b in secondary progressive MS. The MRI machine manufacturers and imaging parameters varied according to the MRI acquisition center. Three experienced observers used a semi-automated local thresholding technique to quantify the hypointense T1 lesion volume on two occasions, separated by a delay. The intra and inter observer coefficients of variation were 3.7% and 4.9% respectively, with similar values derived for images obtained at all three sites. There was a generally high level of agreement between the lesion volumes obtained by the three raters. However, a modest but significant measurement drift was identified between the first and second sessions for one of the three raters, highlighting the very real possibility of measurement drift even for experienced observers. Our results support the increasing role for T1 hypointense lesion volume as an outcome measure in multicenter phase III MS treatment trials.

Key Words: T1 black hole • magnetic resonance imaging • multiple sclerosis

Multiple Sclerosis, Vol. 6, No. 4, 237-240 (2000)
DOI: 10.1177/135245850000600405


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
S. Schach, M. Scholz, J.S. Wolinsky, and L. Kappos
Pooled historical MRI data as a basis for research in multiple sclerosis - a statistical evaluation
Multiple Sclerosis, May 1, 2007; 13(4): 509 - 516.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
B. Benedetti, D.J. Rigotti, S. Liu, M. Filippi, R.I. Grossman, and O. Gonen
Reproducibility of the Whole-Brain N-Acetylaspartate Level across Institutions, MR Scanners, and Field Strengths
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 72 - 75.
[Abstract] [Full Text] [PDF]



Advertisement